Who invested in Skyhawk Therapeutics?
Skyhawk Therapeutics's investors include Fidelity, Alexandria Venture Investments, GreatPoint Ventures and Good Growth Capital.

United States · Venture startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Skyhawk Therapeutics and see its new rounds in your feed.Start following
Funding summaryUpdated 27 Oct 2026
$133Mraised across 1 round since 2021, from 1 source
Source recorded
From Skyhawk Therapeutics's own website: 2 founders.
Skyhawk Therapeutics's investors include Fidelity, Alexandria Venture Investments, GreatPoint Ventures and Good Growth Capital.
Skyhawk Therapeutics has raised $133M across 1 round since 2021.
Skyhawk Therapeutics's most recent round was a Venture of $133M in Sept 2021.
Its most recent round, $133M in Sept 2021, is also its largest on record.
Skyhawk Therapeutics's first round on record, in Sept 2021, was backed by Fidelity, Alexandria Venture Investments and GreatPoint Ventures and 1 others.
Skyhawk Therapeutics's latest named round is a Venture, in Sept 2021.
Skyhawk Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.